###begin article-title 0
###xml 61 65 <span type="species:ncbi:10090">Mice</span>
NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: BS MF TSB. Performed the experiments: BS WH JB MJ ZB JF CD MC DV. Analyzed the data: BS WH JB MJ ZB JF CD RV FY MC PW HM JWC MBS JC DV SH LR SG MF TSB. Contributed reagents/materials/analysis tools: PW HM MBS JC. Wrote the paper: BS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Chronic granulomatous disease (CGD), an inherited disorder of the NADPH oxidase in which phagocytes are defective in generating superoxide anion and downstream reactive oxidant intermediates (ROIs), is characterized by recurrent bacterial and fungal infections and by excessive inflammation (e.g., inflammatory bowel disease). The mechanisms by which NADPH oxidase regulates inflammation are not well understood.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 190 197 190 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 211 215 211 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 553 560 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 968 976 <span type="species:ncbi:9606">patients</span>
We found that NADPH oxidase restrains inflammation by modulating redox-sensitive innate immune pathways. When challenged with either intratracheal zymosan or LPS, NADPH oxidase-deficient p47phox-/- mice and gp91phox-deficient mice developed exaggerated and progressive lung inflammation, augmented NF-kappaB activation, and elevated downstream pro-inflammatory cytokines (TNF-alpha, IL-17, and G-CSF) compared to wildtype mice. Replacement of functional NADPH oxidase in bone marrow-derived cells restored the normal lung inflammatory response. Studies in vivo and in isolated macrophages demonstrated that in the absence of functional NADPH oxidase, zymosan failed to activate Nrf2, a key redox-sensitive anti-inflammatory regulator. The triterpenoid, CDDO-Im, activated Nrf2 independently of NADPH oxidase and reduced zymosan-induced lung inflammation in CGD mice. Consistent with these findings, zymosan-treated peripheral blood mononuclear cells from X-linked CGD patients showed impaired Nrf2 activity and increased NF-kappaB activation.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
These studies support a model in which NADPH oxidase-dependent, redox-mediated signaling is critical for termination of lung inflammation and suggest new potential therapeutic targets for CGD.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 339 343 339 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 348 352 348 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 430 434 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 442 446 442 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 454 456 454 456 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ph</underline>
###xml 464 466 464 466 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ox</underline>
###xml 645 648 645 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Reeves1">[1]</xref>
###xml 650 653 650 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Fuchs1">[2]</xref>
###xml 655 658 655 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Bianchi1">[3]</xref>
###xml 802 805 798 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Tasaka1">[4]</xref>
###xml 807 810 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Rahman1">[5]</xref>
The lung is an interface where inhaled microbes and antigens interact with host defense cells. Pathogen recognition receptors (PRRs) such as toll-like receptors (TLRs) sample microbial motifs and initiate signaling that may result in NADPH oxidase activation. NADPH oxidase activation requires translocation of the cytoplasmic subunits p47phox, p67phox, and p40phox and rac to the membrane-bound flavocytochrome consisting of gp91phox and p22phox (phox, phagocyte oxidase). NADPH oxidase activation leads to generation of superoxide anion and downstream reactive oxidant intermediates (ROIs) and activation of neutrophil antimicrobial proteases [1], [2], [3]. ROIs have been implicated in the pathogenesis of lung diseases through several mechanisms, including cellular injury and NF-kappaB activation [4], [5].
###end p 9
###begin p 10
###xml 230 233 230 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Marciano1">[6]</xref>
###xml 323 326 323 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Siddiqui1">[7]</xref>
###xml 352 355 352 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Gallin1">[8]</xref>
###xml 357 360 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-LekstromHimes1">[9]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Brown1">[10]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Bylund1">[11]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Morgenstern1">[12]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Segal1">[13]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Segal2">[14]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-vandeLoo1">[15]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Romani1">[16]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Schappi1">[17]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Yao1">[18]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Gao1">[19]</xref>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
###xml 377 382 <span type="species:ncbi:10090">mouse</span>
Chronic granulomatous disease (CGD) is an inherited disorder of NADPH oxidase characterized by life-threatening bacterial and fungal infections and by abnormally exuberant inflammatory responses (e.g., inflammatory bowel disease) [6]. "Mulch pneumonitis" is a hyper-inflammatory response in CGD patients to fungal pneumonia[7]. Studies in CGD patients [8], [9], [10], [11] and mouse models [12], [13], [14], [15], [16], [17], [18], [19] point to excessive inflammation in CGD resulting from intrinsic defect(s) in immune regulation.
###end p 10
###begin p 11
###xml 207 214 207 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Jackson1">[20]</xref>
###xml 227 231 227 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup>-</italic>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Pollock1">[21]</xref>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
We evaluated whether NADPH oxidase activity would counterbalance the immediate pro-inflammatory events that follow PRR signaling by interacting with redox-sensitive pathways to dampen inflammation. Using p47phox-/-[20] and gp91phox-deficient [21] mice that lack NADPH oxidase function, we show that NADPH oxidase limits inflammation by attenuating the pro-inflammatory transcription factor NF-kappaB and by activating Nrf2, an anti-inflammatory transcription factor. Our studies demonstrate pharmacological activation of Nrf2 as a potential therapeutic strategy in CGD. This work identifies NADPH oxidase as a critical regulator of innate immunity and provides novel understanding of mechanisms that regulate lung inflammation.
###end p 11
###begin title 12
Results and Discussion
###end title 12
###begin title 13
NADPH Oxidase Down-Regulates Zymosan-Induced Lung Inflammation
###end title 13
###begin p 14
###xml 458 465 458 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 679 683 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Gantner1">[22]</xref>
###xml 520 525 <span type="species:ncbi:4932">yeast</span>
We asked whether NADPH oxidase, which is activated by bacterial and fungal pathogens, would have a role in restraining lung inflammation induced by microbial motifs. We selected microbial products rather than live bacterial or fungal pathogens to specifically evaluate NADPH oxidase as a regulator of inflammation independently of its antimicrobial function; thus a limitation of these studies is that they intentionally do not encapsulate the complexity of in vivo infection models. Since zymosan is a pro-inflammatory yeast cell wall product comprised predominantly of particulate beta-glucan that ligates TLR2 and is a potent activator of NADPH oxidase via dectin-1 signaling [22], we used intratracheal zymosan to induce sterile lung inflammation. Lungs were harvested between 6 hours to 25 days after a single administration of zymosan.
###end p 14
###begin p 15
###xml 62 71 62 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g001">Figure 1A</xref>
###xml 90 97 90 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 199 208 199 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g001">Figure 1B</xref>
###xml 348 357 348 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g001">Figure 1C</xref>
###xml 398 405 398 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 398 405 398 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 947 954 947 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 947 954 947 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1050 1065 1050 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g001">Figure 1D and E</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 955 959 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
Wildtype (WT) mice developed mild peribronchial inflammation (Figure 1A). In contrast, p47phox-/- (CGD) mice developed a robust and persistent inflammatory response following zymosan administration (Figure 1B). The kinetics of zymosan-induced histological lung inflammation in WT and CGD mice demonstrate the dramatic difference between genotypes (Figure 1C). The early inflammatory response in p47phox-/- mice was principally neutrophilic (days 1 to 3). Well-defined pyogranulomatous lesions consisting of foci of neutrophils surrounded by lymphohistiocytic infiltrates were present on day 7 after zymosan administration. On days 14 and 25, the neutrophilic component of the infiltrates was reduced compared to earlier time points and the inflammation was predominantly lymphohistiocytic. Bronchoalveolar lavage fluid (BALF) cytology showed persistence of predominantly neutrophilic inflammation through day 14 after zymosan administration in p47phox-/- mice, whereas BALF neutrophilic leukocytosis in WT mice normalized by day 7 (>90% macrophages; Figure 1D and E). These results demonstrate that resolution of lung inflammation is impaired by loss of NADPH oxidase activity.
###end p 15
###begin title 16
###xml 3 10 3 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
p47phox-/- mice develop increased zymosan-induced lung inflammation compared to wildtype (WT) mice.
###end title 16
###begin p 17
###xml 47 54 47 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 47 54 47 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
Representative lung histology of WT (A) and p47phox-/- (CGD) mice (B) at days 3, 7, 14, 25 after i.t. zymosan. All slides are H&E stained, 20x, and are representative of at least 3 mice per genotype per time point. C) Percent of lung parenchyma with consolidation or granulomatous inflammation. Bronchoalveolar lavage fluid (BALF) neutrophil (D) and macrophage (E) concentrations. 2-way ANOVA showed a significant difference between genotypes in % lung inflammation (p<0.0001) and BALF neutrophil concentration (p<0.0001), with significant differences at the indicated time points by Boneferroni post-test. *, p<0.01; **, p<0.001).
###end p 17
###begin title 18
NADPH Oxidase Regulates Pro-Inflammatory Cytokine Production and NF-kappaB Activation
###end title 18
###begin p 19
###xml 189 196 185 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 189 196 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 223 232 219 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g002">Figure 2A</xref>
###xml 278 285 271 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 278 285 271 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 466 473 452 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 466 473 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
We measured a number of pro-and anti-inflammatory cytokines present in BALF at days 1, 3 and 7 after i.t. zymosan treatment. TNF-alpha, IL-17, and G-CSF levels in BALF were increased in p47phox-/- mice compared to WT mice (Figure 2A). IL-1beta concentration was increased in p47phox-/- mice on day 3, but not at other time points, whereas BALF levels of interferon-gamma, IL-2, IL-4, IL-6, IL-10, IL-12, KC, MCP-1, MIP-2, and TGF-beta were similar between WT and p47phox-/- mice (data not shown).
###end p 19
###begin title 20
###xml 127 134 123 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 127 134 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
Intratracheal zymosan treatment results in higher levels of pro-inflammatory cytokines and NF-kappaB activation in lungs of p47phox-/- mice.
###end title 20
###begin p 21
###xml 71 78 67 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 71 78 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 222 229 214 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 222 229 214 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 559 566 543 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 559 566 543 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 678 685 658 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 678 685 658 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 712 720 692 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
A) BALF levels of TNF-alpha, IL-17, and G-CSF in wild type (WT) and p47phox-/- (CGD) mice administered i.t. zymosan. Note that the Y-axes in the TNF-alpha and IL-17 graphs are in log-scale. The interaction of genotype (p47phox-/- vs. WT) and time was assessed by 2-way ANOVA and was significant for each of the 3 cytokines (p<0.001). Bonferroni post-test was used to test for significance at each time point (*, p<0.05). B) Whole lung NF-kappaB activation measured by bioluminescence imaging over the chest after i.v. luciferin in NF-kappaB reporter mice (p47phox-/-/HLL and WT/HLL). C) NF-kappaB dependent luciferase activity in bone marrow-derived macrophages (BMDMs) from p47phox-/-/HLL and WT/HLL mice after in vitro stimulation with zymosan (20 microg/ml). For (B) and (C), 2-way ANOVA indicated p<0.0001 between genotypes with significant differences at the indicated time points by Bonferroni post-test. *, p<0.05; **, p<0.01; ***, p<0.001).
###end p 21
###begin p 22
###xml 185 192 177 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 185 192 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 215 222 207 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 215 222 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 320 324 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sadikot1">[23]</xref>
###xml 338 345 326 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 481 488 465 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 481 488 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 596 603 576 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 596 603 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 736 745 716 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g002">Figure 2B</xref>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
Since NF-kappaB induces the expression of several pro-inflammatory genes and is influenced by redox status, we evaluated whether NF-kappaB activation was differentially regulated in p47phox-/- and WT mice. Using p47phox-/-/HLL and WT/HLL mice that express luciferase under the control of an NF-kappaB dependent promoter [23], we measured in vivo luciferase expression using bioluminescence imaging. Zymosan-induced whole lung NF-kappaB activation was significantly augmented in p47phox-/-/HLL compared to WT/HLL mice. NF-kappaB-dependent luciferase expression peaked at 2 days post-zymosan in p47phox-/-/HLL mice (6.3-fold above baseline), whereas luciferase activity was not increased above baseline in WT/HLL mice at this time point (Figure 2B).
###end p 22
###begin p 23
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 121 128 117 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 121 128 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 191 200 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g002">Figure 2C</xref>
Consistent with these in vivo findings, zymosan treatment also resulted in increased NF-kappaB activation in isolated p47phox-/- bone marrow-derived macrophages (BMDMs) compared to WT BMDMs (Figure 2C). As expected, WT BMDMs had augmented superoxide production in response to zymosan and PMA as measured by chemiluminescence, whereas CGD macrophages failed to do so (data not shown).
###end p 23
###begin p 24
###xml 107 114 103 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 107 114 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 179 187 175 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g001">Figure 1</xref>
###xml 528 535 516 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 528 535 516 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 542 550 530 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
Whereas whole lung NF-kappaB activation peaked at day 2 and returned to unstimulated levels by day 6 in p47phox-/-/HLL mice, histological lung inflammation continued to progress (Figure 1), arguing that NF-kappaB activation in whole lungs is not simply a non-specific marker of inflammation. These findings are consistent with NF-kappaB activation having a role in initiating the early inflammatory cascade while down-stream cytokines and additional pathways play important roles in maintenance of persistent inflammation in p47phox-/- mice. In vitro data using isolated macrophages further support the role of NADPH oxidase as a negative regulator of zymosan-induced NF-kappaB activation.
###end p 24
###begin p 25
###xml 57 64 57 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 321 328 318 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 321 328 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 635 642 632 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 635 642 632 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 772 779 766 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 772 779 766 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1029 1036 1020 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1029 1036 1020 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1204 1211 1195 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1204 1211 1195 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
We examined whether the inflammatory dysregulation in p47phox-/- mice after zymosan could be explained by differences in surface expression of PRRs, binding of zymosan, or impaired clearance of beta-glucan. Using fluorescently tagged zymosan (Alexa Fluor 488), no difference in zymosan binding or phagosomal uptake in p47phox-/- and WT macrophages occurred. Surface expression of TLR2 (anti-TLR2; eBioscience, San Diego, CA) and dectin-1 (anti-Dectin-1 mAb, 2A11 was a gift from Gordon Brown, PhD, University of Aberdeen, UK) in unstimulated macrophages and at 15 and 60 minutes after zymosan stimulation was similar between WT and p47phox-/- cells (data not shown). We also tested whether clearance of beta-glucan, the principal component of zymosan, was defective in p47phox-/- mice. In fact, levels of beta-glucan in BALF (measured by Fungitell assay; Associates of Cape Cod, East Falmouth, MA) were similar or greater in WT mice, a finding that may reflect increased clearance as a result of enhanced lung inflammation in p47phox-/- mice (data not shown). These results point to NADPH oxidase-regulated signaling events accounting for the differences in the inflammatory phenotypes between WT and p47phox-/- mice, rather than differences at the level of binding to surface receptors.
###end p 25
###begin p 26
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 155 161 155 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 155 161 155 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Pollock1">[21]</xref>
###xml 307 313 307 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 338 345 338 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 338 345 338 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 414 420 414 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 446 461 446 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g003">Figure 3A and B</xref>
###xml 478 485 478 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 574 580 570 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 574 580 570 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 625 634 621 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g003">Figure 3C</xref>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
###xml 680 685 <span type="species:ncbi:10090">mouse</span>
Since it is possible that p47phox can modulate inflammation independently of NADPH oxidase, we evaluated zymosan-induced lung inflammation in X-linked gp91phox-/ CGD mice [21]. We selected a single time point (6 days). The histological lung inflammatory response and inflammatory cell influx in BALF in gp91phox-/ mice were similar to p47phox-/- mice, except for a trend towards fewer macrophages in BALF from gp91phox-/ mice at this time point (Figure 3A and B). Similar to p47phox-/- mice, i.t. zymosan-induced lung NF-kappaB activation was significantly increased in gp91phox-/ mice compared to similarly treated WT mice (Figure 3C). These consistent findings in two different mouse models support the critical role of NADPH oxidase in down-regulating inflammation as opposed to an individual phox protein functioning independently of NADPH oxidase or an artifact introduced during generation of one of the knockout colonies.
###end p 26
###begin title 27
###xml 90 94 86 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 90 95 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup>-</italic>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Intratracheal zymosan caused increased lung inflammation and NF-kappaB activation, in gp91phox-deficient (X-linked CGD) versus wildtype mice.
###end title 27
###begin p 28
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup>-</italic>
###xml 279 286 279 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 279 286 279 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 295 301 295 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 295 301 295 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 397 401 397 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup>-</italic>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 416 420 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
A) Representative lung section of gp91phox-deficient mouse 6 days after i.t. zymosan showing extensive inflammation (H&E, 100x). Similarly treated wildtype (WT) mice had no lung inflammation (not shown). B) On day 6 after i.t. zymosan, both NADPH oxidase deficient genotypes (p47phox-/- and gp91phox-/) had similar BALF neutrophilic leukocytosis, whereas monocytes predominated in WT BALF. C) gp91phox-deficient/HLL mice had increased whole lung NF-kappaB activation compared to WT/HLL mice.
###end p 28
###begin p 29
###xml 367 371 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Gantner1">[22]</xref>
###xml 373 377 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-DeLeo1">[24]</xref>
###xml 458 473 454 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g004">Figure 4A and B</xref>
###xml 501 510 493 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g004">Figure 4C</xref>
###xml 518 525 510 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 518 525 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 560 568 552 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 637 644 625 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 637 644 625 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 685 694 673 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g004">Figure 4D</xref>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
We next asked whether ligation of other PRRs would lead to augmented lung inflammation and NF-kappaB activation in CGD compared to WT mice as did zymosan. Lipopolysachharide (LPS), a bacterial cell wall constituent, ligates CD14/TLR4 and causes a redistribution of NADPH oxidase components in neutrophils that primes the respiratory burst in response to other agents [22], [24]. Similar to zymosan, i.t. treatment with LPS induced greater lung inflammation (Figure 4A and B) and NF-kappaB activation (Figure 4C) in p47phox-/- compared to WT mice. In addition, in vitro LPS stimulation induced greater NF-kappaB activation in isolated p47phox-/- macrophages compared to WT macrophages (Figure 4D). These consistent results using microbial motifs that ligate distinct PRRs underscore a broad role of NADPH oxidase in down-regulating inflammation.
###end p 29
###begin title 30
###xml 4 8 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
CGD mice develop increased lipopolysaccharide-induced lung inflammation and NF-kappaB activation compared to wildtype (WT) mice.
###end title 30
###begin p 31
###xml 25 32 25 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 25 32 25 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 169 176 165 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 169 176 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 427 434 411 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 427 434 411 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 508 515 488 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 508 515 488 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 735 742 715 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 735 742 715 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
Wildtype (WT)/HLL and p47phox-/- /HLL (CGD) mice were administered intratracheal (i.t.) LPS (3 microg/g per mouse). Representative lung histology of a WT/HLL (A) and p47phox-/-/HLL (B) mouse 6 days after i.t. LPS (H&E, 100x). Minimal to no lung inflammation was present in WT/HLL mice, whereas mixed neutrophilic and lymphohistiocytic infiltrates involving approximately10% of the lung and interstitial edema was present in p47phox-/-/HLL mouse lungs. Whole lung NF-kappaB activation (C) was augmented in p47phox-/-/HLL mice administered i.t. LPS compared to similarly treated WT/HLL mice (2-way ANOVA, p<0.0001, with Bonferroni post-test showing significant differences between genotypes at the indicated time points). D) Isolated p47phox-/-/HLL bone marrow-derived macrophages had augmented NF-kappaB activation in response to LPS compared to similarly treated WT/HLL macrophages (2-way ANOVA, p<0.0001). *, p<0.05; **, p<0.01; ***, p<0.001.
###end p 31
###begin title 32
NADPH Oxidase in Hematopoietic Cells, but Not Lung Stromal Cells, Is Essential to Restrain Zymosan-Induced Lung Inflammation
###end title 32
###begin p 33
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Geiszt1">[25]</xref>
###xml 503 512 503 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g005">Figure 5A</xref>
###xml 603 618 603 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g005">Figure 5B and C</xref>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
Since NADPH oxidase isoforms exist in several non-hematopoietic cells and have diverse physiological functions [25], we evaluated whether NADPH oxidase in hematopoietic cells is required to restrain inflammation by generating mouse chimeras in which either the hematopoietic or lung stromal cell population harbor a functional NADPH oxidase. In all bone marrow chimeras, the donor genotype determined NADPH oxidase competence in circulating neutrophils, confirming that the transplants were successful (Figure 5A). The lung inflammatory response to zymosan was entirely dependent on the donor genotype (Figure 5B and C). These results show that NADPH oxidase in hematopoietic cells is required to restrain excessive zymosan-induced inflammation, whereas NADPH oxidase in non-hematopoietic lung stromal cells appears to be dispensable.
###end p 33
###begin title 34
Bone marrow chimera experiments demonstrate that NADPH oxidase in hematopoietic cells, but not lung stromal cells, is required to restrain zymosan-induced lung inflammation.
###end title 34
###begin p 35
###xml 22 29 22 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 138 145 138 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 1166 1170 <span type="species:ncbi:10090">mice</span>
###xml 1283 1287 <span type="species:ncbi:10090">mice</span>
Wild type (WT) and p47phox-/- (CGD) mice were administered myeloablative total body irradiation, and rescued with marrow-derived WT or p47phox-/- donor cells. The transplants were as follows: WT donor/CGD recipient (n = 3); CGD donor/WT recipient (n = 3); WT donor/WT recipient (n = 2); CGD donor/CGD recipient (n = 2); the latter two transplants were performed as specificity controls for artifacts introduced by transplantation. Recipient mice were administered i.t. zymosan at 31 days after transplant. Seven days later, peripheral blood and lungs were harvested. A) NADPH oxidase activity in peripheral neutrophils of transplanted mice was evaluated using the fluorescent probe, dihydrorhodamine 123 (DHR). In a representative experiment, neutrophils were unstimulated (top row) or stimulated with PMA (100 ng/ml) (bottom row) to activate NADPH oxidase. Hydrogen peroxide, a metabolite of NADPH oxidase activation, activates DHR fluorescence. In all transplants, the donor genotype determined NADPH oxidase competence. B) Representative lung histology (H&E, 40x) and C) percent of lung parenchyma with consolidation or granulomatous inflammation in transplanted mice at day 7 after i.t. zymosan administration. Percent lung inflammation was significantly greater in transplanted mice with CGD compared to wildtype donors (abbreviated, "D" in the figure) (unpaired t-test, p<0.0001), whereas recipient (abbreviated, "R" in the figure) genotype had no effect on the inflammatory response.
###end p 35
###begin title 36
NADPH Oxidase Is Required for Zymosan-Induced Nrf2 Activation
###end title 36
###begin p 37
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Lee1">[26]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Papaiahgari1">[27]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sekhar1">[28]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Kensler1">[29]</xref>
###xml 459 466 459 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 459 466 459 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
Previous studies in cultured cells using a flavoenzyme inhibitor have shown that NADPH oxidase can be an upstream regulator of Nrf2 [26], [27], [28], a redox-sensitive transcription factor that is critical for suppression of inflammatory responses [29]. We asked whether zymosan activates Nrf2 and whether Nrf2 activation is NADPH oxidase-dependent. If so, we reasoned that defective Nrf2 activation could contribute to the hyper-inflammatory phenotype in p47phox-/- mice.
###end p 37
###begin p 38
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Cullinan1">[30]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Higa1">[31]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Kobayashi1">[32]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Higa1">[31]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Rachakonda1">[33]</xref>
Typically, Cullin 3 (CUL3) directs the ubiquitination and subsequent proteasome-dependent degradation of Nrf2 [30], [31], [32]. Oxidation or adduction of critical cysteine residues on the adapter protein, Keap1, induces a conformational change that inhibits its ability to bind to CUL3, thereby abrogating Nrf2 ubiquitination and allowing accumulation of transcriptionally active Nrf2 in the nucleus [31], [33]. NADPH oxidase-derived ROIs could activate Nrf2 via oxidation of redox-sensitive cysteine residues on Keap1.
###end p 38
###begin p 39
In initial studies, we found that zymosan up-regulates nuclear localization of Nrf2 in RAW264.7 cells by performing western blots from nuclear protein extracts obtained 4 hours after zymosan treatment. We then co-transfected epitope-tagged constructs for Keap1 and CUL3 into RAW 264.7 macrophages and stimulated the cells with zymosan. By co-immunoprecipitation, we found reduced association between Keap1 and CUL3 at 4 hours after zymosan, suggesting that zymosan activates Nrf2 by interfering with Keap1/CUL3 interactions (data not shown).
###end p 39
###begin p 40
###xml 57 64 57 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 159 166 159 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 303 310 303 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 303 310 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 367 382 367 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g006">Figure 6A and B</xref>
###xml 592 599 592 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 592 599 592 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 796 803 796 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 796 803 796 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 818 827 818 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g006">Figure 6C</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
To investigate whether Nrf2 activation is impaired in p47phox-/- mice, we measured Nrf2 nuclear localization in BMDMs stimulated with zymosan. Unstimulated p47phox-/- and WT macrophages had similar recovery of Nrf2 from nuclear extracts; however, increased nuclear Nrf2 was detected in WT but not in p47phox-/- macrophages after 1 and 4 hours of zymosan stimulation (Figure 6A and B). The NQO1 promoter contains an antioxidant response element (ARE), the target sequence for Nrf2, and is known to be Nrf2-inducible. We therefore evaluated protein levels of NQO1 in cytoplasmic extracts of p47phox-/- and WT macrophages following zymosan stimulation as an indirect readout of Nrf2 activation. Consistent with Nrf2 nuclear translocation, NQO1 expression was induced by zymosan in WT, but not in p47phox-/-, macrophages (Figure 6C).
###end p 40
###begin title 41
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Zymosan-induced Nrf2 nuclear translocation is NADPH oxidase-dependent in isolated macrophages and in vivo.
###end title 41
###begin p 42
###xml 22 29 22 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 256 263 252 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 256 263 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 516 522 512 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 516 522 512 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 530 537 526 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 530 537 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 775 779 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">mice</span>
Wild type (WT) and p47phox-/- (CGD) bone marrow-derived macrophages (BMDMs) cultured in DMEM media with 10% serum were stimulated with zymosan (20 micro/ml). A) Western blot for Nrf2 and Tata box binding protein (TBP) in nuclear fractions of BMDMs from p47phox-/- and WT mice at baseline, 1, 4, and 24 hours after zymosan. B) Densitometry from 3 separate experiments. p<.05 by ANOVA using Tukey post-test. C) Western blot showing expression of NQO1 in cytoplasmic extracts. D) Western blot for nuclear Nrf2 from gp91phox-/ and p47phox-/- macrophages treated with vehicle, zymosan (20 microg/ml), or the Nrf2 agonist electrophiles, CDDO-Im (1.0 microM) or sulforaphane (50 microM), for 4 hours. E) Nrf2 DNA binding activity of lung nuclear extracts in unstimulated (baseline) mice and 6 days after i.t. zymosan. n = 3-6 mice per group. Lung Nrf2 binding activity in zymosan-stimulated WT mice was significantly greater than that in unstimulated WT mice (student's t-test, p<0.05), whereas zymosan treatment had no effect on lung Nrf2 activation in CGD mice.
###end p 42
###begin p 43
###xml 64 71 64 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby1">[34]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Juge1">[35]</xref>
###xml 283 290 283 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 394 400 394 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 408 415 408 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 408 415 408 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 506 515 506 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g006">Figure 6D</xref>
###xml 524 532 524 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
Since zymosan failed to induce Nrf2 nuclear translocation in p47phox-/- macrophages, we asked whether well-characterized electrophilic Nrf2 agonists 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) [34] and sulforaphane [35] were capable of activating Nrf2 in p47phox-/- mouse macrophages. CDDO-Im and sulforaphane were both able to induce Nrf2 nuclear translocation in gp91phox-/ and p47phox-/- macrophages, whereas zymosan failed to increase Nrf2 translocation above vehicle control (Figure 6D). These in vitro studies indicate a stimulus-dependent defect in Nrf2 activation in NADPH oxidase-deficient cells, suggesting that NADPH oxidase-produced ROIs are required for Nrf2 activation following zymosan treatment but are dispensable for electrophile-induced Nrf2 activation.
###end p 43
###begin p 44
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 169 176 169 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 169 176 169 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 185 191 185 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/</sup>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/</sup></italic>
###xml 408 417 408 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g006">Figure 6E</xref>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
We then evaluated whether Nrf2 activation was NADPH oxidase-dependent in vivo. We measured induction of Nrf2 activity in whole lung nuclear protein extracts from WT, p47phox-/- and gp91phox-/ mice using an ELISA-based method that measures binding of Nrf2 to its oligonucleotide target. Lung Nrf2 activity was similar at baseline between WT and CGD mice, but was increased after i.t. zymosan only in WT mice (Figure 6E). Taken together, these studies support a role for NADPH oxidase in activating Nrf2 and point to defective Nrf2 activation as a possible mechanism for excessive inflammation in CGD.
###end p 44
###begin title 45
###xml 77 84 77 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 85 89 <span type="species:ncbi:10090">Mice</span>
CDDO-Im Attenuates the Zymosan-Stimulated Hyper-Inflammatory Phenotype in p47phox-/- Mice
###end title 45
###begin p 46
###xml 71 78 71 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 629 644 625 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g007">Figure 7A and B</xref>
###xml 752 761 748 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g007">Figure 7C</xref>
###xml 818 825 814 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 818 825 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 934 943 926 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g007">Figure 7D</xref>
###xml 1055 1059 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Ruddy1">[36]</xref>
###xml 1215 1222 1203 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1215 1222 1203 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1354 1361 1338 1345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1354 1361 1338 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1455 1464 1439 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g007">Figure 7E</xref>
###xml 1582 1589 1562 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1582 1589 1562 1569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 826 830 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 1227 1231 <span type="species:ncbi:10090">mice</span>
###xml 1366 1370 <span type="species:ncbi:10090">mice</span>
###xml 1594 1598 <span type="species:ncbi:10090">mice</span>
To evaluate the role of Nrf2 in the hyper-inflammatory phenotype of p47phox-/- mice, we tested whether CDDO-Im would attenuate zymosan-induced lung inflammation in these mice. We performed pretreatment experiments in which intraperitoneal (i.p.) CDDO-Im or vehicle was administered daily from days -1 to +2 in relation to i.t. zymosan, and lungs were harvested on day +3. The mean percentage of lung parenchyma involved by inflammatory cell infiltration was significantly greater in the zymosan plus vehicle group compared to the zymosan plus CDDO-Im group (34+/-5% vs. 13+/-7%, respectively; p = 0.01), based on blinded review (Figure 7A and B). Consistent with these findings, BALF neutrophils were significantly reduced following CDDO-Im treatment (Figure 7C). Cytokines shown to be increased in zymosan-treated p47phox-/- mice compared to WT mice, including TNF-alpha, IL-17, and G-CSF, were reduced in BALF by CDDO-Im treatment (Figure 7D). In addition, BALF levels of IL-23 (an inducer of Th17 cell expansion) and LIX (an IL-17-stimulated chemokine [36]) were reduced by CDDO-Im treatment. We also performed experiments to measure the impact of CDDO-Im treatment on zymosan-induced NF-kappaB activation in p47phox-/-/HLL mice. By bioluminescence imaging, no differences were identified in NF-kappaB dependent luciferase activity in the lungs of p47phox-/-/HLL mice up to 3 days after zymosan plus CDDO-Im compared to the zymosan plus vehicle group (Figure 7E). In separate experiments, we found that CDDO-Im did not affect zymosan-induced NF-kappaB activation in BMDM from p47phox-/-/HLL mice (data not shown).
###end p 46
###begin title 47
###xml 127 134 127 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
The triterpenoid, CDDO-Im, a Nrf2 inducer, reduces zymosan-induced lung inflammation and pro-inflammatory BALF cytokines in p47phox-/- mice.
###end title 47
###begin p 48
###xml 91 98 91 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 91 98 91 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 243 250 243 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 243 250 243 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 688 695 680 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 688 695 680 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1233 1240 1213 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1233 1240 1213 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1413 1416 1393 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 701 705 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 1241 1245 <span type="species:ncbi:10090">mice</span>
###xml 1417 1421 <span type="species:ncbi:10090">mice</span>
CDDO-Im (0.2 mg/mouse by i.p. injection) or vehicle (control) was administered daily to p47phox-/- mice from day -1 to +2 in relation to i.t. zymosan, and BALF and lungs were harvested on day +3. Representative H&E stained lung sections of p47phox-/- mice administered zymosan plus vehicle (A) or zymosan plus CDDO-Im (B). Neutrophil (C) and cytokine (D) concentrations were assessed in BALF obtained at day 3 after zymosan treatment. Significant differences were observed for neutrophils (p = 0.03), IL-23 (p = 0.008), IL-17 (p = 0.02), TNF-alpha (p = 0.02), and LIX (p = 0.03) (Mann-Whitney two-tailed test). E) Lung NF-kappaB activation, measured by bioluminescence, was similar in p47phox-/- /HLL mice administered zymosan plus CDDO-Im versus zymosan plus vehicle (Two-way ANOVA, p = NS). F) Representative Western blot of lung homogenates for NQO1 and (G) densitometry (normalized to beta-actin) (G) for 3 mice per genotype per treatment (p<.05 by ANOVA using Tukey post-test). Untreated  =  no experimental manipulation; zymosan  =  i.t. zymosan plus i.p. vehicle; zymosan + CDDO-Im  =  i.t. zymosan plus i.p. CDDO-Im. H) Measurement of Nrf2 activity by TransAMtrade mark ELISA from whole lung nuclear protein extracts from p47phox-/- mice treated with zymosan plus vehicle or zymosan plus CDDO-Im. Results are presented as increase over background O.D. measurement in lung nuclear protein samples from Nrf2-/- mice (p<.05 using unpaired t-test).
###end p 48
###begin p 49
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 118 126 118 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 193 200 193 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 348 355 348 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 362 377 362 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g007">Figure 7F and G</xref>
###xml 539 548 539 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g007">Figure 7H</xref>
###xml 645 652 645 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
As an indicator of Nrf2 activity in vivo, we measured protein expression of NQO1 in lung homogenates. Consistent with in vitro findings, no differences in NQO1 expression were found between p47phox-/- mice with or without zymosan treatment; however, CDDO-Im administration significantly increased NQO1 protein levels in lungs of zymosan-treated p47phox-/- mice (Figure 7F and G). Similar results were obtained using quantitative RT-PCR to measure NQO1 mRNA expression (data not shown). In addition, Nrf2 activity was increased by CDDO-Im (Figure 7H), which, together with augmented NQO1 expression, shows the effectiveness of this treatment for in vivo Nrf2 activation.
###end p 49
###begin p 50
###xml 127 134 127 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 507 518 507 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g008">Figure 8A&#8211;D</xref>
###xml 881 892 881 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g008">Figure 8E&#8211;G</xref>
###xml 1014 1021 1014 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1014 1021 1014 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1066 1073 1066 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1066 1073 1066 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 1022 1026 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
In additional studies, we used a 'therapeutic' model to evaluate the effects of CDDO-Im on established lung inflammation in p47phox-/- mice. In these studies, i.p. CDDO-Im or vehicle was administered daily from days +2 to +5 in relation to i.t. zymosan, and lungs were harvested on day +6. Pyogranulomatous lesions involving approximately 40% of the lung, characterized by a central collection of neutrophils surrounded by lymphohistiocytic inflammation, occurred in mice that received zymosan and vehicle (Figure 8A-D). In contrast, mice administered zymosan and CDDO-Im had inflammatory infiltrates limited to <10% of the lung. The remaining areas of infiltrate in zymosan-treated mice in the CDDO-Im group contained pyknotic cells and inflammatory debris, with few viable cells. These apoptotic inflammatory cells were positive for cleaved (activated) caspase-3 immunostaining (Figure 8E-G), suggesting that CDDO-Im treatment induces inflammatory cell apoptosis when given after the onset of inflammation in p47phox-/- mice. Taken together, these results show p47phox-/- mice can be rescued from hyper-inflammatory responses by pharmacological NADPH oxidase-independent interventions targeting the Nrf2 pathway.
###end p 50
###begin title 51
###xml 56 63 56 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
CDDO-Im reduces zymosan-induced lung inflammation in p47phox-/- mice in therapeutic studies by induction of apoptosis.
###end title 51
###begin p 52
###xml 181 188 181 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 562 569 562 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 733 740 733 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 733 740 733 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 814 821 814 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 814 821 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1555 1562 1555 1562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 1555 1562 1555 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 741 745 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 940 945 <span type="species:ncbi:10090">mouse</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
###xml 1230 1236 <span type="species:ncbi:9986">rabbit</span>
###xml 1563 1567 <span type="species:ncbi:10090">mice</span>
CDDO-Im (i.p. 0.2 mg/mouse) or vehicle was administered daily from days 2 to 5 and lungs were harvested on day 6 in relation to i.t. zymosan administration. A) Lung section of a p47phox-/- mouse administered zymosan and vehicle shows well-defined granulomatous lesions occupying approximately 40% of the lung (H&E, 20x). B) Higher magnification (400x) shows dense cellular granulomata composed of neutrophils and lymphohistiocytic infiltrates in mouse treated with zymosan and vehicle. C) In contrast, scant areas of inflammation were present in the lungs of p47phox-/- mice administered zymosan and CDDO-Im (H&E, 20x). D) At higher magnification (400x), small foci of degraded inflammatory cells were observed in CDDO-Im treated p47phox-/- mice. E-G) Cleaved caspase-3 immunostaining was augmented in lungs of p47phox-/- mice administered zymosan and CDDO-Im compared to zymosan and vehicle. E) Lung section of zymosan and vehicle-treated mouse shows dense inflammatory lesions with occasional apoptosis (H&E, 200x). F) Lung section of zymosan and CDDO-Im-treated mouse shows sparse areas of inflammation composed of apoptotic cells that are positive (brown staining) for cleaved caspase-3 (H&E, 200x). G) Same section as B with rabbit isotype shows background staining within alveolar epithelial cells, but not in areas of inflammation (H&E, 200x). Addition of blocking peptide eliminated anti-cleaved caspase-3 staining with the exception of background activity, confirming specificity of staining (data not shown). Sections are representative of 4 p47phox-/- mice per treatment group.
###end p 52
###begin title 53
###xml 81 88 81 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 15 19 <span type="species:ncbi:10090">Mice</span>
###xml 89 93 <span type="species:ncbi:10090">Mice</span>
Nrf2-Deficient Mice Have an Inflammatory Response Intermediate between WT and p47phox-/- Mice
###end title 53
###begin p 54
###xml 147 154 147 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 242 249 242 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 242 249 242 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 394 397 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 514 525 510 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g009">Figure 9A&#8211;C</xref>
###xml 535 538 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 672 681 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g009">Figure 9D</xref>
###xml 734 737 726 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 759 768 751 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g009">Figure 9E</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
As Nrf2 activity is critical for the suppression of hyper-inflammatory responses and our studies indicated that Nrf2 is activated by NADPH oxidase in vivo, we asked whether Nrf2-/- mice would have a hyper-inflammatory phenotype similar to p47phox-/- mice. Nrf2-/- mice were crossed with NF-kappaB reporter (HLL) mice and compared to WT/HLL reporter mice after administration of zymosan. In Nrf2-/-/HLL mice, histological evidence of lung inflammation was more prominent than in WT/HLL mice at day 3 after zymosan (Figure 9A-C). In Nrf2-/-/HLL mice, the neutrophilic influx in BALF was significantly greater than in WT/HLL mice at day 3 after zymosan, but abated by day 6 (Figure 9D). Lung NF-kappaB activation was similar between Nrf2-/-/HLL and WT/HLL mice (Figure 9E). These results suggest that Nrf2 is primarily required for early control of zymosan-induced inflammation and does not appear to affect NF-kappaB activation. Taken together, these results point to activation of Nrf2 as being one, but not the only, pathway by which NADPH oxidase regulates inflammation.
###end p 54
###begin title 55
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Nrf2-/- mice develop increased i.t. zymosan-induced inflammation compared to wild type (WT) mice.
###end title 55
###begin p 56
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 524 527 524 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 792 795 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
A) Representative lung of WT mouse at day 3 after zymosan showing no inflammation (H&E, 20x). B) Nrf2-/- mouse lung showing approximately 15% of lung involved with inflammatory infiltrates at day 3 after zymosan (H&E, 20x). C) Higher power magnification (200x) showing a predominantly histiocytic alveolar infiltrate with scattered foci of neutrophils and apoptotic cells in the lung of an Nrf2-/- mouse. The above is representative of 3 mice per genotype. D) BALF neutrophilic leukocytosis was significantly greater in Nrf2-/- versus WT mice at 3 days after zymosan. By day 6, the BALF neutrophil count was similar in both genotypes. There was no significant difference in the BALF macrophage concentration. E) Zymosan-induced lung NF-kappaB activation was similar in WT/HLL (n = 6) and Nrf2-/-/HLL (n = 7) mice (Two-way ANOVA, p = NS).
###end p 56
###begin p 57
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby2">[37]</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
Since CDDO-Im can affect both Nrf2-dependent and -independent pathways [37], we asked whether CDDO-Im would dampen inflammation in Nrf2-/- mice. Histological lung inflammation was similar at day 3 after i.t. zymosan administration in Nrf2-/- mice that received i.p. CDDO-Im (n = 7) versus vehicle (n = 8) from days -1 to +2 in relation to zymosan (data not shown), lending support to the notion that CDDO-Im attenuates inflammation in CGD mice primarily through Nrf2 activation.
###end p 57
###begin title 58
###xml 57 62 <span type="species:ncbi:9606">Human</span>
NADPH Oxidase Regulates Nrf2 and NF-kappaB Activation in Human Peripheral Blood Mononuclear Cells
###end title 58
###begin p 59
###xml 214 224 210 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g010">Figure 10A</xref>
###xml 439 449 431 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009631-g010">Figure 10B</xref>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
###xml 476 481 <span type="species:ncbi:9606">human</span>
###xml 509 514 <span type="species:ncbi:10090">mouse</span>
We next asked whether NADPH oxidase influences Nrf2 and NF-kappaB activation in human cells by studying purified peripheral blood mononuclear cells (PBMCs) from normal donors and X-linked CGD patients. As shown in Figure 10A, zymosan-induced Nrf2 activation was uniformly defective in CGD PBMCs. In contrast, NF-kappaB activation from the same nuclear extracts was augmented in zymosan-stimulated CGD PBMCs compared to normal donor PBMCs (Figure 10B). Thus, our studies using human PBMCs were consistent with mouse data, and further support a key role for NADPH oxidase in regulating signaling through Nrf2 and NF-kappaB pathways.
###end p 59
###begin title 60
###xml 77 82 <span type="species:ncbi:9606">human</span>
NADPH oxidase augments Nrf2 activation and restrains NF-kappaB activation in human PBMCs.
###end title 60
###begin p 61
###xml 50 58 <span type="species:ncbi:9606">patients</span>
PBMCs from normal donors (n = 8) and X-linked CGD patients (n = 5) were stimulated with zymosan (20 microg/ml). A) Nrf2 activation. B) NF-kappaB activation. *, p<0.05 comparing normal donor and CGD PBMCs.
###end p 61
###begin p 62
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 566 571 <span type="species:ncbi:9606">human</span>
The principal function of NADPH oxidase is to generate ROIs and activate neutrophil granular proteases that kill invading pathogens. The second and less recognized function of NADPH oxidase is to counterbalance these early pro-inflammatory events to limit tissue injury. Indeed, our studies suggest that inflammation may not be passively self-limited and that activation of anti-inflammatory pathways is required to protect the host from excessive inflammation. Consistent with studies in mice, NADPH oxidase activates Nrf2 while restraining NF-kappaB activation in human PBMCs. We propose a model in which NADPH oxidase-derived ROIs play a central role in limiting microbial ligand-induced inflammation by interacting in parallel with redox-sensitive targets that regulate NF-kappaB and Nrf2 activation.
###end p 62
###begin p 63
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Kensler1">[29]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Thimmulappa1">[38]</xref>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Thimmulappa2">[39]</xref>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Li1">[40]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Rangasamy1">[41]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sakurai1">[42]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Zakkar1">[43]</xref>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Wei1">[44]</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Zhu1">[45]</xref>
###xml 508 511 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 892 896 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby1">[34]</xref>
###xml 898 902 898 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby2">[37]</xref>
###xml 904 908 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby3">[46]</xref>
###xml 910 914 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby4">[47]</xref>
###xml 916 920 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Ji1">[48]</xref>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
Our results in Nrf2-/- mice are consistent with other studies demonstrating a hyper-inflammatory phenotype [29], including increased inflammatory responses and mortality after systemic LPS challenge [38], [39]. Activation of Nrf2 likely mitigates ROI-induced inflammation and cellular injury [40], [41], [42], [43], [44], [45]. While our data point to Nrf2 as an important anti-inflammatory regulator activated by NADPH oxidase, the intensity and duration of inflammation were greater in CGD compared to Nrf2-/- mice, arguing that dysregulation of Nrf2-independent pathways also contribute to excessive inflammation in CGD. That CDDO-Im activates Nrf2 independently of NADPH oxidase and limits inflammation suggests that Nrf2 activation may be a promising therapeutic strategy in controlling inflammatory complications in CGD. CDDO-Im may also have Nrf2-independent anti-inflammatory effects [34], [37], [46], [47], [48]. Use of double knockout CGD x Nrf2-/- mice will clarify whether the anti-inflammatory effect of CDDO-Im is Nrf2-specific.
###end p 63
###begin p 64
###xml 270 277 262 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 270 277 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 706 710 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Li2">[49]</xref>
###xml 712 716 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liu1">[50]</xref>
###xml 871 875 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Lee2">[51]</xref>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
In addition to defective Nrf2 activation, failure to down-regulate NF-kappaB activation likely contributes to the exaggerated inflammatory response in CGD. Zymosan and LPS treatment result in a marked increase and prolongation of NF-kappaB activation in the lungs of p47phox-/- mice and in isolated macrophages. CDDO-Im treatment increased lung Nrf2, but not NF-kappaB, activation, and NF-kappaB activation was not altered in zymosan-treated Nrf2-/- mice. Together, these findings suggest that NADPH oxidase regulates Nrf2 and NF-kappaB signaling in parallel to restrain inflammatory signaling induced by PRR activation. Other studies show the potential for cross-regulation of NF-kappaB and Nrf2 pathways [49], [50]. Indeed, it was recently shown that Keap1 binds to, and is required for, Cullin 3-based ubiquitination of IKKbeta, leading to downregulation of NF-kappaB [51].
###end p 64
###begin p 65
###xml 179 183 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Brown1">[10]</xref>
###xml 185 189 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Bylund1">[11]</xref>
###xml 307 311 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Yao1">[18]</xref>
###xml 355 359 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Zmijewski1">[52]</xref>
###xml 373 374 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 375 376 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 599 603 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Koay1">[53]</xref>
###xml 719 723 703 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Koay1">[53]</xref>
###xml 1009 1016 989 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1367 1371 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Kono1">[54]</xref>
###xml 1373 1377 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Rusyn1">[55]</xref>
###xml 1638 1642 1598 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Asehnoune1">[56]</xref>
###xml 1657 1661 1617 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Reynaert1">[57]</xref>
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
###xml 1337 1341 <span type="species:ncbi:10090">mice</span>
Our findings are consistent with prior studies of human CGD PMBCs in which expression of NF-kappaB-dependent pro-inflammatory cytokines was increased following treatment with LPS [10], [11]. In addition, CGD mice have greater cigarette smoke-induced lung injury and NF-kappaB activation compared to WT mice [18]. Using acatalasemic mice, Zmijewski et al. [52] showed that H2O2 reduced NF-kappaB activation in neutrophils and diminished LPS-induced lung injury in mice. In contrast, we previously reported that early activation of NF-kappaB was reduced in the lungs of CGD mice treated with i.p. LPS [53] compared to wildtype mice, although inflammation was similar. The difference in results between our previous study [53] and the current work may be related to the route of LPS administration (i.p. versus i.t. in the current study), time of measurement of lung NF-kappaB activation in relation to LPS administration (90 minutes versus later time points in the current study), and the assay used to measure in vivo NF-kappaB activation (gel shift assay, which measures the presence of NF-kappaB dimers in the nucleus, versus use of HLL reporter mice to measure NF-kappaB-driven transcriptional activity in the current study). Other previous studies found that hepatic NF-kappaB activation and injury were reduced in CGD compared to WT mice after exposure to toxins [54], [55]. Together, these results underscore the complexity of the interaction of ROIs and NF-kappaB activation that is likely influenced by the specific stimulus, site of inflammation, kinetics of ROI generation, and numerous redox-sensitive targets that can activate [56] or inactivate [57] NF-kappaB.
###end p 65
###begin p 66
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Fan1">[58]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Romani1">[16]</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Gelderman1">[59]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-GeorgeChandy1">[60]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Cheng1">[61]</xref>
###xml 369 373 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Jancic1">[62]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Romani1">[16]</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sussan1">[63]</xref>
In summary, our studies elucidate an under-appreciated role for ROIs in termination of innate immune responses through regulation of crucial intracellular signaling pathways. We and others have previously shown specific roles for NADPH oxidase in regulating neutrophil-endothelial cell interactions [58] and dendritic cell and T-cell phenotypes [16], [59], [60], [61], [62]. Romani et al. [16] demonstrated a central role of NADPH oxidase in determining the balance between Th17 and regulatory T-cell development through activation of tryptophan catabolism. These studies together with our current results show that NADPH oxidase calibrates immune homeostasis at multiple levels. Therefore, it is not surprising that attempts at antioxidant therapy to reduce tissue inflammation and injury have been unsuccessful. Manipulation of critical oxidant-regulated signaling pathways, like Nrf2, may be a more promising approach for prevention and treatment of inflammatory lung injury [63] and other disorders of inflammation. In addition, treatments that enhance Nrf2 activity could be beneficial for treating inflammatory complications of CGD.
###end p 66
###begin title 67
Materials and Methods
###end title 67
###begin title 68
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 68
###begin p 69
###xml 42 46 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Jackson1">[20]</xref>
###xml 160 167 160 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 347 350 347 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Chan1">[64]</xref>
###xml 554 558 554 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
###xml 554 558 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox</sup></italic>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Pollock1">[21]</xref>
###xml 629 636 629 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 629 636 629 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 700 707 696 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 700 707 696 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 738 742 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sadikot1">[23]</xref>
###xml 748 751 744 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 942 949 934 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox&#8722;/&#8722;</sup>
###xml 942 949 934 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>phox&#8722;/&#8722;</sup></italic>
###xml 1045 1049 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sadikot1">[23]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 593 600 <span type="species:ncbi:185739">Pollack</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 657 660 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 895 900 <span type="species:ncbi:10090">mouse</span>
###xml 1001 1005 <span type="species:ncbi:10090">mice</span>
###xml 1051 1055 <span type="species:ncbi:10090">Mice</span>
Mice with a targeted disruption of the p47phox gene have a defective NADPH oxidase, rendering phagocytes incapable of generating measurable superoxide [20]. p47phox-/- mice were derived from C57BL/6 and 129 intercrosses, and were backcrossed 14 generations in the C57BL/6 background. Age and sex-matched C57BL/6 WT mice were used as controls. Nrf2-/- mice were generated from C57BL/6 and 129 intercrosses as previously described [64], and were backcrossed 9 generations in the C57BL/6 lineage. Inbred C57BL/6 mice were used as WT controls. X-linked (gp91phox-deficient) mice were generated by Pollack et al. [21] We crossbred p47phox-/- mice with NF-kappaB HIV-LTR/luciferase (HLL) reporter mice (p47phox-/- /HLL) as previously described [23]. Nrf2-/-/HLL mice were derived in a similar fashion. This system enables visualization of NF-kappaB activation longitudinally at the level of the whole mouse and isolated organs and cells. WT and p47phox-/- bone marrow-derived macrophages (BMDMs) from these mice were generated as previously described [23]. Mice were maintained under specific pathogen free conditions and all procedures performed on animals were approved by the Institutional Animal Care and Use Committee at Roswell Park Cancer Institute and Vanderbilt University, and complied with all state, federal, and NIH regulations.
###end p 69
###begin title 70
Intratracheal Zymosan Administration
###end title 70
###begin p 71
###xml 264 268 <span type="species:ncbi:10090">Mice</span>
###xml 332 336 <span type="species:ncbi:10090">Mice</span>
###xml 754 758 <span type="species:ncbi:10090">Mice</span>
Zymosan (Sigma, St. Louis, MO) was diluted to a concentration of 2.5 mg/ml in saline, sonicated until the particles were suspended homogenously and frozen at -20degreesC. Prior to use, the zymosan stock was diluted to 0.8 mg/mL and autoclaved to ensure sterility. Mice were anesthetized with i.p. injections of Avertin (380 mg/kg). Mice were restrained, hair plucked from the throat and the area cleansed with betadine and alcohol. A medial cut was made in the skin above the trachea followed by a medial cut in the tracheal sheath. A BD Insyte (BD, Franklin Lakes, NJ) cannula was inserted into the trachea just above the bifurcation and 25 ul of the zymosan suspension followed by 25 microl of air were injected. The incision was closed with a suture. Mice were given 1 ml of sterile PBS IP for re-hydration, placed on a heating pad and monitored for recovery.
###end p 71
###begin title 72
Bioluminescence Imaging
###end title 72
###begin p 73
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Sadikot1">[23]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized, received 1 mg of D-luciferin retro-orbitally, and were imaged as described previously [23], in an IVIS cooled charged coupled device (Xenogen Corporation, Alameda, CA). Data were collected and analyzed using Living Image v.2.50 (Xenogen Corporation, Alameda, CA) and IgorPro (Wavemetrics, lake Oswego, OR) software.
###end p 73
###begin title 74
CDDO-Im (1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole)
###end title 74
###begin p 75
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Liby1">[34]</xref>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Thimmulappa2">[39]</xref>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
CDDO-Im is a semi-synthetic triterpenoid that potently induces Nrf2 activity[34]. For each experiment, CDDO-Im was dissolved in a 10% DMSO 10% cremaphor-EL PBS solution as previously described [39]. Intraperitoneal CDDO-Im (0.2 mg/mouse per day) or vehicle was administered at different times in relation to zymosan challenge.
###end p 75
###begin title 76
Cytokine and Chemokine Measurement
###end title 76
###begin p 77
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed by CO2 asphyxiation, and bronchoalveolar lavage (BAL) was performed using a total of 2 ml of cold saline per animal. BALF IL-23 and LIX (a neutrophil chemokine) were assessed by ELISA per the manufacturer's instructions (eBioscience, San Diego, CA and R&D Systems, Minneapolis, MN, respectively). All other cytokines and chemokines were measured at the Roswell Park Cancer Institute core facility flow cytometry laboratory using the multiplexed flow cytometry assay in which several cytokines can be quantitated simultaneously on the same sample. The Luminex 100 platform is used to acquire data from soluble bead arrays in which each bead set has a separate capture reagent attached to the surface that is directed against a single cytokine or chemokine.
###end p 77
###begin title 78
Lung Histopathology
###end title 78
###begin p 79
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
After sacrifice and bronchoalveolar lavage, mouse lungs were infused with 10% neutral buffered formalin via the trachea. Parrafin-embedded sections were prepared and stained with hematoxylin and eosin (H&E). The percentage of lung involved by granulomatous or consolidative inflammation was scored in each mouse as follows: 0%, 5%, 10%, and then by 10% increments (e.g., 20%, 30%, 40%, etc.). The predominant inflammatory cell type was scored as neutropilic or lymphohistiocytic. Histopathology was assessed by one of us (BHS) in a blinded fashion.
###end p 79
###begin p 80
###xml 453 459 <span type="species:ncbi:9986">Rabbit</span>
###xml 558 564 <span type="species:ncbi:9986">rabbit</span>
To evaluate for apoptosis, immunohistochemistry to detect cleaved caspase-3 on paraffin-embedded sections was performed. Activation of caspase-3 requires proteolytic cleavage of its inactive zymogen. Cleaved caspase-3 (Asp175) polyclonal antibody (Cell Signaling, Danvers, MA) detects the large fragment of activated caspase-3 resulting from cleavage adjacent to Asp175. The cleaved caspase-3 antibody (0.33 microg/ml) was applied to slides for 1 hour. Rabbit IgG isotype and blocking peptide were used as specificity controls. A biotinylated secondary anti-rabbit antibody followed by the Elite ABC reagent (Avidin: Biotinylated enzyme Complex) and diaminobenzidine-based peroxidase substrate were added per the manufacturer's instruction (Vector Labs, Burlingame, CA), and counterstained with hematoxylin. The color reaction product results in brown staining.
###end p 80
###begin title 81
Bone Marrow Transplantation
###end title 81
###begin p 82
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">137</sup>
###xml 555 556 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 886 890 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009631-Mardiney1">[65]</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 577 582 <span type="species:ncbi:10090">mouse</span>
###xml 595 599 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
Donor mice were sacrificed using cervical dislocation to ensure the collection of unadulterated material. Next, femurs and tibias were removed, the tips excised, and the bone marrow flushed out using cold 0.1% BSA solution in PBS. Bone marrow cells were then washed and resuspended in cold PBS. Recipient mice received myeloablative conditioning with 12Gy of 137Cs gamma total body irradiation (0.74Gy/min) split 6Gy a day for two days. Eight hours after the final radiation dose, mice were injected in the tail vein with the donor bone marrow cells (1x106 cells per recipient mouse). Recipient mice were administered i.t. zymosan at 31 days after transplant. Seven days later, peripheral blood and lungs were harvested. NADPH oxidase activity in peripheral neutrophils of transplanted mice was evaluated using the fluorescent probe, dihydrorhodamine 123 (DHR), as previously described [65].
###end p 82
###begin title 83
Nuclear Protein Extraction
###end title 83
###begin p 84
At the indicated time points, samples were placed on ice, washed with PBS, and cytoplasmic and nuclear extracts were obtained using the NE-PER kit (Pierce, Rockford, IL) in the presence of Complete mini, EDTA-free protease inhibitor cocktail (Roche Diagnostics, Switzerland) at 4degreesC. Then samples stored at -80degreesC.
###end p 84
###begin title 85
Analysis of Nrf2 Activation
###end title 85
###begin p 86
Western blot analysis of nuclear protein fractions was performed by Odyssey system (LI-COR Bioscience, Nebraska USA), using antibodies specific for Nrf2, TBP, beta-actin (Santa Cruz Technology), NQO1 (Cell Signaling Technology). In whole lung nuclear protein extracts, Nrf2 was measured by the TransAM Nrf2 ELISA (Active Motif, Carlsbad, CA) using the manufacturers instructions.
###end p 86
###begin title 87
###xml 15 23 <span type="species:ncbi:9606">Patients</span>
PBMCs from CGD Patients and Normal Donors
###end title 87
###begin p 88
###xml 1168 1169 1152 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1232 1233 1210 1211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1316 1317 1284 1285 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 1645 1650 <span type="species:ncbi:10090">mouse</span>
Whole blood from X-linked CGD patients and normal donors were collected at the NIH Clinical Center in heparinized tubes and processed immediately. Serum was obtained from a distinct healthy donor in serum separator tubes, aliquoted, and frozen at -20degreesC until ready for use. Cell culture media was prepared from RPMI 1640 supplemented with 2 mM l-glutamine, 100 U of penicillin/mL, 100 microg streptomycin/mL, 10 mM HEPES buffer, and 10% donor serum, and filter sterilized. Zymosan (Sigma) was re-suspended in sterile filtered sodium chloride 0.85% (Quality Biologicals), autoclaved, and kept at 4degreesC until ready for use. Whole blood from each donor was diluted in a 1:1 ratio with HBSS without divalent cations. PBMCs were collected following standard separation on Lymphocyte-Separation medium (Mediatech). The PBMC pellet underwent hypotonic lysis with ACK Lysing buffer (Quality Biologicals) to remove erythrocytes, then washed twice with HBSS and re-suspended in cell culture media. PBMCs were enumerated by hemacytometer and confirmed >95% viable by trypan blue exclusion. PBMCs from each subject were inoculated in duplicate into 6 well plates at 3x106 cells/mL, allowed to adhere for 2 hours at 37degreesC in 5% CO2, then stimulated with zymosan (20 microg/ml), and incubated at 37degreesC in 5% CO2. After 1 and 4 hours of stimulation, cell culture medium was removed, each well was washed twice in phosphate-buffered saline, and the plate was frozen at -80degreesC until ready for nuclear protein extraction. Nuclear extracts were isolated, and Nrf2 activity was measured by the TransAM Nrf2 ELISA, using the same methods as mouse samples. NF-kappaB activation in nuclear extracts was measured by relA (p65) DNA binding using the TransAM NF-kappaB ELISA kit. All subjects gave written informed consent for research testing under approved protocols of the NIH.
###end p 88
###begin title 89
Statistics
###end title 89
###begin p 90
Prism software was used for statistical analysis and to display graphical data. Inter-group comparisons were made using the non-parametric Mann-Whitney method. A p-value of <0.05 was considered statistically significant. For time-course experiments, two-way ANOVA with Bonferroni post-testing at individual time points was used.
###end p 90
###begin p 91
We thank Vivian Siegel, PhD, Vanderbilt University School of Medicine, for reviewing the manuscript and providing helpful comments.
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
Killing activity of neutrophils is mediated through activation of proteases by K+ flux.
###end article-title 93
###begin article-title 94
Novel cell death program leads to neutrophil extracellular traps.
###end article-title 94
###begin article-title 95
Restoration of NET formation by gene therapy in CGD controls aspergillosis.
###end article-title 95
###begin article-title 96
Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome.
###end article-title 96
###begin article-title 97
Antioxidant therapeutic targets in COPD.
###end article-title 97
###begin article-title 98
Gastrointestinal involvement in chronic granulomatous disease.
###end article-title 98
###begin article-title 99
Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.
###end article-title 99
###begin article-title 100
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease.
###end article-title 100
###begin article-title 101
###xml 14 19 <span type="species:ncbi:9606">human</span>
Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease.
###end article-title 101
###begin article-title 102
ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease.
###end article-title 102
###begin article-title 103
Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B.
###end article-title 103
###begin article-title 104
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 149 170 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
###end article-title 104
###begin article-title 105
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation.
###end article-title 105
###begin article-title 106
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Acid aspiration-induced lung inflammation and injury are exacerbated in NADPH oxidase-deficient mice.
###end article-title 106
###begin article-title 107
Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.
###end article-title 107
###begin article-title 108
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
###end article-title 108
###begin article-title 109
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice.
###end article-title 109
###begin article-title 110
###xml 120 124 <span type="species:ncbi:10090">mice</span>
Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice.
###end article-title 110
###begin article-title 111
###xml 166 170 <span type="species:ncbi:10090">mice</span>
Role of NADPH oxidase in the mechanism of lung neutrophil sequestration and microvessel injury induced by Gram-negative sepsis: studies in p47phox-/- and gp91phox-/- mice.
###end article-title 111
###begin article-title 112
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
The p47phox mouse knock-out model of chronic granulomatous disease.
###end article-title 112
###begin article-title 113
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production.
###end article-title 113
###begin article-title 114
Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2.
###end article-title 114
###begin article-title 115
p47(phox) deficiency impairs NF-kappaB activation and host defense in Pseudomonas pneumonia.
###end article-title 115
###begin article-title 116
Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly.
###end article-title 116
###begin article-title 117
The Nox family of NAD(P)H oxidases: host defense and beyond.
###end article-title 117
###begin article-title 118
###xml 101 106 <span type="species:ncbi:9606">human</span>
Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells.
###end article-title 118
###begin article-title 119
NADPH oxidase and ERK signaling regulates hyperoxia-induced Nrf2-ARE transcriptional response in pulmonary epithelial cells.
###end article-title 119
###begin article-title 120
NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols.
###end article-title 120
###begin article-title 121
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway.
###end article-title 121
###begin article-title 122
The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase.
###end article-title 122
###begin article-title 123
Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy.
###end article-title 123
###begin article-title 124
Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.
###end article-title 124
###begin article-title 125
Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3.
###end article-title 125
###begin article-title 126
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
###end article-title 126
###begin article-title 127
Molecular basis for chemoprevention by sulforaphane: a comprehensive review.
###end article-title 127
###begin article-title 128
Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment.
###end article-title 128
###begin article-title 129
Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.
###end article-title 129
###begin article-title 130
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis.
###end article-title 130
###begin article-title 131
Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
###end article-title 131
###begin article-title 132
Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinflammatory and oxidizing effects of diesel exhaust chemicals.
###end article-title 132
###begin article-title 133
###xml 89 93 <span type="species:ncbi:10090">mice</span>
Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice.
###end article-title 133
###begin article-title 134
Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
###end article-title 134
###begin article-title 135
Activation of Nrf2 in endothelial cells protects arteries from exhibiting a proinflammatory state.
###end article-title 135
###begin article-title 136
###xml 68 73 <span type="species:ncbi:9606">human</span>
Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival.
###end article-title 136
###begin article-title 137
Identification of Nrf2-dependent airway epithelial adaptive response to proinflammatory oxidant-hypochlorous acid challenge by transcription profiling.
###end article-title 137
###begin article-title 138
The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells.
###end article-title 138
###begin article-title 139
###xml 121 125 <span type="species:ncbi:10090">mice</span>
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.
###end article-title 139
###begin article-title 140
The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
###end article-title 140
###begin article-title 141
Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.
###end article-title 141
###begin article-title 142
NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK.
###end article-title 142
###begin article-title 143
KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.
###end article-title 143
###begin article-title 144
Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury.
###end article-title 144
###begin article-title 145
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Impaired pulmonary NF-kappaB activation in response to lipopolysaccharide in NADPH oxidase-deficient mice.
###end article-title 145
###begin article-title 146
NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease.
###end article-title 146
###begin article-title 147
Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators.
###end article-title 147
###begin article-title 148
Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.
###end article-title 148
###begin article-title 149
Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta.
###end article-title 149
###begin article-title 150
TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase.
###end article-title 150
###begin article-title 151
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species.
###end article-title 151
###begin article-title 152
Th17 development and autoimmune arthritis in the absence of reactive oxygen species.
###end article-title 152
###begin article-title 153
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.
###end article-title 153
###begin article-title 154
Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes.
###end article-title 154
###begin article-title 155
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.
###end article-title 155
###begin article-title 156
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein.
###end article-title 156
###begin article-title 157
###xml 49 55 <span type="species:ncbi:10090">murine</span>
Enhanced host defense after gene transfer in the murine p47phox- deficient model of chronic granulomatous disease.
###end article-title 157
###begin p 158
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 158
###begin p 159
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by Chronic Granulomatous Disorder Research Trust and NIH/NIAID R01AI079253 (BHS), NIH/NCI CA115556 (MLF), NIH HL61419 (TSB), the U.S. Department of Veterans Affairs (TSB), and Korea Healthcare Technology R&D Project A084891 (MJ). This research was supported, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 159

